LEONE, ALDO
 Distribuzione geografica
Continente #
AS - Asia 256
NA - Nord America 255
EU - Europa 200
SA - Sud America 36
AF - Africa 10
Totale 757
Nazione #
US - Stati Uniti d'America 245
SG - Singapore 111
RU - Federazione Russa 94
IT - Italia 47
CN - Cina 44
VN - Vietnam 41
BR - Brasile 24
BD - Bangladesh 20
DE - Germania 18
FR - Francia 17
HK - Hong Kong 17
GB - Regno Unito 9
AR - Argentina 8
MX - Messico 7
FI - Finlandia 6
TH - Thailandia 6
CI - Costa d'Avorio 5
NL - Olanda 5
PK - Pakistan 4
IN - India 3
IQ - Iraq 3
JP - Giappone 3
ZA - Sudafrica 3
CA - Canada 2
EC - Ecuador 2
KR - Corea 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
ES - Italia 1
ET - Etiopia 1
IE - Irlanda 1
NG - Nigeria 1
PH - Filippine 1
Totale 757
Città #
Singapore 52
Ashburn 33
Chandler 30
San Jose 26
Moscow 22
Ho Chi Minh City 19
Hong Kong 17
Beijing 16
Hanoi 14
Hefei 11
Naples 10
Munich 9
Santa Clara 9
New York 7
Dallas 6
Lauterbourg 6
Millbury 6
Nocera Inferiore 6
Lawrence 5
The Dalles 5
Amsterdam 4
Bangkok 4
Los Angeles 4
Norwalk 4
Wilmington 4
Boston 3
Buffalo 3
Capaccio 3
Chicago 3
Council Bluffs 3
Des Moines 3
Frankfurt am Main 3
Helsinki 3
Rome 3
São Paulo 3
Tokyo 3
Turku 3
Düsseldorf 2
Lahore 2
London 2
Mexico City 2
Nottingham 2
Orem 2
Poplar 2
Quilmes 2
Redondo Beach 2
Rio de Janeiro 2
Roubaix 2
Seattle 2
Seoul 2
Shijiazhuang 2
Toronto 2
Abuja 1
Acalanes Ridge 1
Addis Ababa 1
Apucarana 1
Atlanta 1
Babahoyo 1
Baghdad 1
Baltimore 1
Basra 1
Bexley 1
Bluffton 1
Bogotá 1
Bologna 1
Brasília 1
Brighton 1
Brooklyn 1
Buenos Aires 1
Bình Dương 1
Cachoeiro de Itapemirim 1
Cagliari 1
Caracaraí 1
Cascavel 1
Cedro 1
Central Square 1
Centurion 1
Charlotte 1
Charqueadas 1
Chennai 1
Cherryville 1
Chiang Mai 1
Columbia City 1
Concord 1
Cuauhtémoc 1
Domérat 1
Dublin 1
Fairfield 1
Falkenstein 1
Ferrara 1
Florence 1
Forlì 1
Goiânia 1
Gurgaon 1
Hanover 1
Harbin 1
Havana 1
Houston 1
Ibarra 1
Karachi 1
Totale 443
Nome #
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 156
Rituximab-containing risk-adapted treatment strategy in nodular lymphocyte predominant hodgkin lymphoma: 7-years follow-up 134
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 130
Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671." 112
Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era" 108
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” 104
Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series 29
Totale 773
Categoria #
all - tutte 2.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 3 0 4 0 5 1 2 3 25 11
2022/202354 5 4 4 1 10 10 0 6 6 5 2 1
2023/202426 1 3 4 4 0 0 1 8 0 0 4 1
2024/2025206 5 6 0 1 1 14 18 11 11 29 82 28
2025/2026406 41 24 54 30 62 14 34 14 43 44 14 32
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 773